跳至主要内容
临床试验/NL-OMON42526
NL-OMON42526已完成不适用

Platelet reactivity and formation of platelet-monocyte complexes in patients with chronic obstructive pulmonary disease (COPD) - COPD reactivity

ongziekten0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • In order to be eligible to participate in this study the COPD subjects must meet all of the following criteria:
  • >40 years
  • Bronchus obstruction detected by spirometry: FEV1/FVC ratio < 70% and postbronchodilatory FEV1<80% (COPD Gold II-IV) and clinical diagnosis confirmed by a pulmonologist.
  • >=10 pack years of smoking

排除标准

  • Use of aspirin or other platelet function inhibitors
  • Chronic inflammatory diseases, such as rheumatoid arthritis, psoriasis, inflammatory bowel diseases , systemic lupus erythematous (SLE)
  • Malignancies
  • Regarding the control subjects the inclusion criteria described above do not apply, however the exclusion criteria do apply.

研究者

发起方
ongziekten

相似试验